Lattuada E, Lanzafame M, Grosso C, Soldani, et al. F. Optimal fosamprenavir regimen to prevent lipid abnormalities. Acta Biomed. 2009;80(3):200-202. Accessed April 22, 2026. https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/1171